GSK Demerger Explained

(9:49)

How to process a Demerger | GSK Haleon Demerger

(3:43)

A signal of change

(1:49)

Market will decide valuation of company, says Haleon CEO

(3:13)

[2022] Pass the GSK Interview | GSK Video Interview

(17:16)

GSK Video Interview Questions and Answers Practice

(20:52)

Dame Emma Walmsley: What does the CEO think?

(8:4)

These are the stocks to buy for the next 10 years

(5:32)

GSK Interview Experience | VIT | CSE | 2023 | Superdream | #placement

(8:3)

Progress on our Aspirational Targets

(11:34)

Emma Walmsley Alludes To GSK's Unethical Conduct.

(5:2)

Brian McNamara speaks at the Exane BNP Paribas 23rd European CEO Conference

(18:21)

Haleon: A global consumer healthcare leader delivering sustainable above market growth

(26:31)

Ep 1: Getting Ahead Together with... a career in STEM

(5:31)

Pharmaceutical giant GlaxoSmithKline closer to splitting in two

(1:25)

Glaxo Gets Ready to Split in Two

(6:39)

GSK’s Consumer Healthcare Business Rebrands As Haleon Ahead Of Spin Off

(2:38)

BVTV: GSK’s big breakup

(1:19)

GSK CEO Emma Walmsley on beating Q4 earnings

(4:47)

GSK CEO Emma Walmsley shares FY 2022 highlights on CNBC

(49)

GSK Spinoff Haleon (HLN UK) Is Biggest New Euro Listing In 10yrs - Index Implications and Overhang

(41)

GSK Wants Vaccine to Get to Those Who Need It Most First

(1:34)

Haleon – Tess Player speaks about GSK's latest demerger

(11:22)

GlaxoSmithKline plc's arm Haleon to list on LSE

(3:1econd)

Distinguished Speaker Series: A Conversation with GSK CEO Emma Walmsley

(50:27)

Drugmaker GSK closer to splitting in two

(1:14)

Big pharma: GSK beats forecasts, but Novartis lags

(1:14)

Glaxosmithkline and Pfizer De-merger to form Haleon

(4:5)

GSK sees sales growth in 2022 after quarterly beat, prepares for spin-off

(1:14)